Objective To review the current status of practical knowledge related to insulin-associated
lipohypertrophy (LH)—an accumulation of fatty subcutaneous nodules commonly caused by …

Lipohypertrophy is a common skin complication associated with insulin-treated diabetes.
The impact of lipohypertrophy as a contributing factor to suboptimal glycemic control …

People with type 1 diabetes mellitus (T1DM) need to take multiple doses of insulin injections
daily throughout their lives. However, a notable portion of people with diabetes mellitus (DM) …

Objective: This study examined subcutaneous tissue changes at sites used by continuous
subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM), and tested …

Panniculitis encompasses a wide variety of skin diseases characterized primarily by
inflammation of the subcutaneous fat. The condition is not an extension of dermatoses of the …

Objective To determine lipohypertrophy (LH) in patients with type 1 diabetes mellitus (T1DM)
on multiple daily insulin injections (MDII) or continuous subcutaneous insulin infusion (CSII) …

Aims: To put forward a scientific hypothesis about the progression of insulin-injection-
induced lipohypertrophy (LH) according to the high-frequency ultrasonic imaging of insulin …

Aims To explore an cost‐effective, convenient method for lipohypertrophy (LH) detection
with a high detection rate, and to construct a classification table for LH, so as to provide …

Diabetes devices, such as insulin pumps, glucose sensors, and integrated automated
insulin delivery systems, have brought about a transformative impact on the management of …

Lipohypertrophy (LH) is a common side effect of insulin treatment in patients with diabetes,
characterized by soft, benign nodules in the subcutaneous tissue. This case report describes …